Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Summit Therapeu ADR (NQ: SMMT ) 18.98 +0.67 (+3.66%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,408,163 Open 18.36 Bid (Size) 19.00 (1) Ask (Size) 19.08 (1) Prev. Close 18.31 Today's Range 18.11 - 19.25 52wk Range 1.890 - 33.89 Shares Outstanding 97,381,774 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Merck Spends Up To $3.3 Billion In An Insurance Policy Against Summit Therapeutics November 14, 2024 Merck is spending up to $3.3 billion in a licensing deal for an anti-PD-1/VEGF drug from China. Via Investor's Business Daily BioNTech Earns Upgrade From Goldman Sachs As Investment Thesis Shifts Toward Cancer Potential November 09, 2024 Goldman Sachs upgrades BioNTech to Buy, highlighting the potential of its cancer drug BNT327 and forecasting strong future revenue amid shifting company focus. Via Benzinga Performance YTD +618.94% +618.94% 1 Month -7.41% -7.41% 3 Month +54.94% +54.94% 6 Month +318.06% +318.06% 1 Year +853.77% +853.77% More News Read More MarketBeat Week in Review – 11/4 - 11/8 November 09, 2024 Via MarketBeat Topics Economy Government Exposures Interest Rates Political 2 Hot Biopharma Stocks to Buy and Hold for 5 Years November 08, 2024 Via The Motley Fool Why Summit Therapeutics Stock Was a Winner Today November 04, 2024 Via The Motley Fool Preview: Summit Therapeutics's Earnings October 29, 2024 Via Benzinga (SMMT) - Analyzing Summit Therapeutics's Short Interest October 10, 2024 Via Benzinga Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo November 04, 2024 Via Benzinga Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer? November 04, 2024 Via MarketBeat Exposures Product Safety This Tencent Music Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday November 04, 2024 Via Benzinga 3 Magnificent Stocks Under $100 to Buy in November November 03, 2024 Via The Motley Fool 2 Dividend Stocks to Buy for a Lifetime of Passive Income November 02, 2024 Via The Motley Fool 3 Stocks That Have Generated 1,000% Returns in Just 2 Years October 31, 2024 Via The Motley Fool Summit Therapeutics Reports Operational Progress and Financial Results for the Third Quarter and Nine Months Ended September 30, 2024 October 30, 2024 From Summit Therapeutics Inc. Via Business Wire From Nuvalent to Nuvectis Pharma: New Report Highlights NXP900's Synergy in NSCLC and Anticipated NXP800 Data Update October 28, 2024 Via News Direct Is Summit Therapeutics a Millionaire Maker? October 27, 2024 Via The Motley Fool Up Over 600% in 2024, Can Summit Therapeutics Stock Keep Rising? October 24, 2024 Via The Motley Fool Billionaire Bob Duggan Snags $33M Miami Penthouse Amid Summit Therapeutics 689% Stock Rally October 24, 2024 Via Benzinga Summit Therapeutics to Host Third Quarter 2024 Financial Results & Operational Progress Call on October 30, 2024 October 23, 2024 From Summit Therapeutics Inc. Via Business Wire Billionaire Israel Englander Just Quietly Took a Stake in This Potentially Lucrative Pharmaceutical Stock. Should You? October 22, 2024 Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session October 16, 2024 Via Benzinga Up 700% This Year, Is It Too Late to Invest in This Stock? October 15, 2024 Via The Motley Fool Better Biotech Stock to Buy With $1,500 Right Now: Viking Therapeutics vs. Summit Therapeutics October 13, 2024 Via The Motley Fool 3 Things You Need to Know If You Buy Summit Therapeutics Stock Today October 12, 2024 Via The Motley Fool 2 Soaring Stocks That Could Climb Another 112% and 120%, According to Wall Street Analysts October 07, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
